Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
5 hedge funds and large institutions have $2.65M invested in Biocept, Inc. in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
19% less capital invested
Capital invested by funds: $3.28M → $2.65M (-$629K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$147K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$147K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GBA
1
Garrison Bradford & Associates
New York
| $923K | – | – | – |
|
|
PCM
2
Perkins Capital Management
Wayzata,
Minnesota
| $698K | +$147K | +1 | +33% |
|
3
Verition Fund Management
Greenwich,
Connecticut
| $498K | – | – | – |
|
|
LP
4
LMR Partners
London,
United Kingdom
| $264K | -$147K | -1 | -33% |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $177K | – | – | – |
|
|
CP
6
Camelot Portfolios
Maumee,
Ohio
| $60K | – | – | – |
|
|
U
7
UBS
Zurich,
Switzerland
| $13K | – | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $8K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
10
Citigroup
New York
| $2K | – | – | – |
|
11
Morgan Stanley
New York
| $2K | – | – | – |
|
|
12
Wells Fargo
San Francisco,
California
| – | -$1K | – | – |
|
BIOC Hedge Fund Activity: Q2 2014 in Review
5 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q2 2014, worth a combined $2.65M — down 19% from $3.28M a quarter earlier.
Fund positioning in BIOC was balanced in Q2 2014: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Perkins Capital Management, adding an estimated $147K. The largest seller was LMR Partners, cutting an estimated $147K.
- 5 institutional investors held Biocept, Inc. (BIOC) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $2.65M of Biocept, Inc. stock for Q2 2014, down 19% quarter-over-quarter.
- 0 funds opened new Biocept, Inc. positions in Q2 2014 and 0 closed out.
- The largest Biocept, Inc. buyer in Q2 2014 was Perkins Capital Management, an estimated $147K added.
- The largest Biocept, Inc. seller in Q2 2014 was LMR Partners, an estimated $147K sold.
Based on aggregated 13F filings for Q2 2014.